{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:40:31Z","timestamp":1776386431348,"version":"3.51.2"},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2013]]},"DOI":"10.2169\/internalmedicine.52.9325","type":"journal-article","created":{"date-parts":[[2013,5,14]],"date-time":"2013-05-14T22:56:52Z","timestamp":1368572212000},"page":"1079-1083","source":"Crossref","is-referenced-by-count":20,"title":["Rituximab Treatment for Adult Purpura Nephritis with Nephrotic Syndrome"],"prefix":"10.2169","volume":"52","author":[{"given":"Hiroaki","family":"Ishiguro","sequence":"first","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Akata","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shota","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kengo","family":"Azushima","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiko","family":"Kanaoka","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromichi","family":"Wakui","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Oshikawa","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyotaka","family":"Nagahama","sequence":"additional","affiliation":[{"name":"Department of Pathology, Yokohama City University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Inayama","sequence":"additional","affiliation":[{"name":"Department of Pathology, Yokohama City University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouichi","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Toya","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Umemura","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Pillebout E, Thervet E, Hill G, et al. Henoch-Schönlein purpura in adults: outcome and prognostic factors. J Am Soc Nephrol 13: 1271-1278, 2002."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Chartapisak W, Opastirakul S, Hodson EM, et al. Interventions forpreventing and treating kidney disease in Henoch-Schönlein Purpura (HSP). Cochrane Database Syst Rev 3: CD005128, 2009.","DOI":"10.1002\/14651858.CD005128.pub2"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Pillebout E, Alberti C, Guillevin L, et al. Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adult patients with severe Henoch Schönlein Purpura. Kidney Int 78: 495-502, 2010.","DOI":"10.1038\/ki.2010.150"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Donnithorne KJ, Atkinson TP, Hinze CH, et al. Rituximab therapy for severe refractory chronic Henoch-Schönlein purpura. J Pediatr 155: 136-139, 2009.","DOI":"10.1016\/j.jpeds.2008.12.049"},{"key":"5","unstructured":"5. Fogazzi GB, Pasquali S, Moriggi M, et al. Long-term outcome of Schönlein-Henoch nephritis in the adult. Clin Nephrol 31: 60-66, 1989."},{"key":"6","unstructured":"6. Shrestha S, Sumingan N, Tan J, Alhous H, McWilliam L, Ballardie F. Henoch Schönlein purpura with nephritis in adults: adverse prognostic indicators in a UK population. QJM 99: 253-265, 2006."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Coppo R, Mazzucco G, Cagnoli L, Lupo A, Schena FP. Long-term prognosis of Henoch-Schönlein nephritis in adults and children. Italian group of renal immunopathology collaborative study on Henoch-Schönlein purpura. Nephrol Dial Transplant 12: 2277-2283, 1997.","DOI":"10.1093\/ndt\/12.11.2277"},{"key":"8","unstructured":"8. Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D. Henoch-Schölein Purpura in adults: Outcome and prognostic factors. J Am Soc Nephrol 13: 1271-1278, 2002."},{"key":"9","unstructured":"9. Davin JC. Henoch-Schönlein purpura nephritis: Pathophysiology, treatment, and future strategy. J Am Soc Nephrol 6: 679-689, 2011."},{"key":"10","unstructured":"10. Pillebout E, Rocha F, Fardet L, Rybojad M, Verine J, Glotz D. Successful outcome using rituximab as the only immunomodulation in Henoch-Schönlein purpura: case report. Nephrol Dial Transplant 26: 2044-2046, 2011."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Maloney DG, Grillo-Lopez AJ, White CA, et al. IDECC2B8 (RIT) anti-CD20 monoclonal antibody therapy in patients with relapsed low grade non-Hodgkin's lymphoma. Blood 90: 2188-2195, 1997.","DOI":"10.1182\/blood.V90.6.2188.2188_2188_2195"},{"key":"12","unstructured":"12. Francois H, Daugas E, Bensman A, Ronco P. Unexpected efficacy of rituximab in multi-relapsing minimal change nephrotic syndrome in the adult: first case report and pathophysiological considerations. Am J Kidney Dis 49: 158-161, 2007."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kurosu N, Sugiura H, Iwasaki C, et al. Successful use of single dose rituximab for the maintenance of remission in a patient with steroid-resistant nephrotic syndrome. Intern Med 48: 1901-1904, 2009.","DOI":"10.2169\/internalmedicine.48.2435"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Sawara Y, Itabashi M, Kojima C, et al. Successful therapeutic use of a single-dose of rituximab on relapse in adults with minimal change nephrotic syndrome. Clin Nephrol 72: 69-72, 2009.","DOI":"10.5414\/CNP72069"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Amemiya N, Takei T, Kojima C, Nokiba H, Itabashi M, Nitta K. Induction of remission following a single dose of rituximab alone in a patient with minimal change nephrotic syndrome. Clin Exp Nephrol 15: 933-936, 2011.","DOI":"10.1007\/s10157-011-0510-5"},{"key":"16","unstructured":"16. Andrew S, Vimal K, Julie G, Abhijit V, Ronald J, Patrick H. Rituximab therapy for membranous nephropathy: A systematic review. Clin J Am Soc Nephrol 4: 734-744, 2009."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ruggenenti P, Cravedi P, Chianca A, Perna A, Ruggiero B, Gaspari F, Rambaldi A, Marasa M, Remuzzi G. Rituximab in idiopathic membranous nephropathy. J Am Soc Nephrol 23: 1416-1425, 2012.","DOI":"10.1681\/ASN.2012020181"},{"key":"18","unstructured":"18. Johnson PWM, Glennie MJ. Rituximab: Mechanisms and applications. Br J Cancer 85: 1619-1623, 2001."},{"key":"19","unstructured":"19. Giagounidis AA, Anhuf J, Schneider P, et al. Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 monoclonal antibody rituximab: A pilot study. Eur J Haematol 69: 95-100, 2002."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Wiestner A, Cho HJ, Asch AS, et al. Rituximab in the treatment of acquired factor VIII inhibitors. Blood 100: 3426-3428, 2002.","DOI":"10.1182\/blood-2002-03-0765"},{"key":"21","unstructured":"21. Davis TA, Grillo-Lopez AJ, McLaughlin P, et al. Rituximab anti -CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: Safety and efficacy of treatment. J Clin Oncol 18: 3135-3143, 2000."},{"key":"22","unstructured":"22. De Vita S, Zaja F, Sacco S, De Candia A, Fanin R, Ferraccioli G. Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: Evidence for a pathogenetic role of B cells. Arthritis Rheum 46: 2029-2033, 2002."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/52\/10\/52_52.9325\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T01:48:01Z","timestamp":1645062481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/52\/10\/52_52.9325\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.52.9325","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}